institutionsInstitution
Curanosticum Wiesbaden-Frankfurt
Curanosticum is a nuclear medicine practice in Wiesbaden and Frankfurt led by Richard Baum, one of the pioneers of peptide receptor radionuclide therapy, offering FAPI PET and investigational radioligand therapies.
Overview
Curanosticum Wiesbaden-Frankfurt describes itself as modern nuclear medicine in the Rhine-Main region: precise diagnostics and individual therapy from an experienced team. Led by Richard Baum, it offers FAPI PET imaging and investigational radioligand therapies alongside established theranostics, and is patient-bookable through an oncology referral.
Location
Wiesbaden, DE
Type
hospital
Website
Newsweek 2026 oncology rank
Not in top 300 listing used
Nuclide score
#41 · 6 points (0 Newsweek + 0 NCI + 6 from 3 linked objects) · ranking
Similar pages
not linked directly; found by shared links- InstitutionExcel Diagnostics and Nuclear Oncology Center
Shares Radioligand therapy (beta emitters) and the tag fcct-directory.
- PersonMichael Lassmann
- InstitutionAll India Institute of Medical Sciences, New Delhi
- PersonWolfgang A. Weber
- TermBecquerel and curie (units of radioactivity)
Shares Lutetium-177 radioligand therapy, Radioligand therapy (beta emitters).
- IdeaFAP theranostics as a pan-cancer stromal strategy
- InstitutionUniversity Hospital Düsseldorf / CIO Düsseldorf
- InstitutionTUM Klinikum rechts der Isar / CCC München